연구성과로 돌아가기

2025 연구자 정보 (183 / 657)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Lee, Young-Jin
(Lee, YJ)
제1저자 Kyungpook Natl Univ, Cell & Matrix Res Inst, Sch Med, Dept Biochem & Cell Biol, Daegu 41944, South Korea

[JCR상위 7.8] Strategic Optimization of Nanoparticle Characteristics to Enhance Tumor Targeting and Doxorubicin Delivery SCIE 7.8 NANOSCIENCE & NANOTECHNOLOGY;PHARMACOLOGY & PHARMACY devi1703@gmail.com; nwpark@knu.ac.kr;
Lev-Zion, R.
(Lev-Zion, R)
Shaare Zedek Med Ctr, Juliet Keidan Inst Pediat Gastroenterol & Nutr, Jerusalem, Israel

[JCR상위 7.8] Tasty & Healthy Flexible Diet Induces clinical and biological Remission in Children and Young Adults with Mild-Moderate Crohn's Disease similar to EEN: results from the "TASTI-MM" randomized, physician-blinded, controlled trial SCIE 7.8 GASTROENTEROLOGY & HEPATOLOGY
Lim, H.
(Lim, H)
Chung Ang Univ Hosp, Dept Internal Med, Seoul, South Korea

[JCR상위 7.8] Long-term Efficacy and Persistence of Subcutaneous Infliximab after Switching from Intravenous Infliximab in patients with Crohn's disease: A Real-World Multicenter Prospective Cohort Study in Korea SCIE 7.8 GASTROENTEROLOGY & HEPATOLOGY
Lim, Y. J.
(Lim, YJ)
Dongguk Univ, Ilsan Hosp, Dept Internal Med, Goyang, South Korea KVY-6446-2024
LIM, Yun Jeong

[JCR상위 7.8] Long-term Efficacy and Persistence of Subcutaneous Infliximab after Switching from Intravenous Infliximab in patients with Crohn's disease: A Real-World Multicenter Prospective Cohort Study in Korea SCIE 7.8 GASTROENTEROLOGY & HEPATOLOGY
Lin, C. C.
(Lin, CC)
Taipei Vet Gen Hosp, Gastroenterol, Taipei, Taiwan

[JCR상위 7.8] Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study SCIE 7.8 GASTROENTEROLOGY & HEPATOLOGY
Lin, W. C.
(Lin, WC)
Mackay Mem Hosp, Internal Med, Taipei, Taiwan
Mackay Mem Hosp, Gastroenterol, Taipei, Taiwan


[JCR상위 7.8] Clinical outcomes and predictive factors differ in acute severe ulcerative colitis for East Asian and Western patients
[JCR상위 7.8] Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study
SCIE 7.8 GASTROENTEROLOGY & HEPATOLOGY
Liu, J.
(Liu, J)
Zhejiang Univ, Sir Run Run Shaw Hosp, Ctr Inflammatory Bowel Dis, Sch Med,Internal Med, Hangzhou, Peoples R China
Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Ctr Inflammatory Bowel Dis,Gastroenterol, Hangzhou, Peoples R China


[JCR상위 7.8] Clinical outcomes and predictive factors differ in acute severe ulcerative colitis for East Asian and Western patients
[JCR상위 7.8] Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study
SCIE 7.8 GASTROENTEROLOGY & HEPATOLOGY
Livovsky, J.
(Livovsky, J)
Shaare Zedek Med Ctr, Juliet Keidan Inst Pediat Gastroenterol & Nutr, Jerusalem, Israel

[JCR상위 7.8] Tasty & Healthy Flexible Diet Induces clinical and biological Remission in Children and Young Adults with Mild-Moderate Crohn's Disease similar to EEN: results from the "TASTI-MM" randomized, physician-blinded, controlled trial SCIE 7.8 GASTROENTEROLOGY & HEPATOLOGY
Lynch, K.
(Lynch, K)
Royal Adelaide Hosp, Internal Med, Adelaide, Australia

[JCR상위 7.8] Clinical outcomes and predictive factors differ in acute severe ulcerative colitis for East Asian and Western patients SCIE 7.8 GASTROENTEROLOGY & HEPATOLOGY
Mahy, G.
(Mahy, G)
Townsville Univ Hosp, Internal Med, Townsville, Australia
Townsville Univ Hosp, Gastroenterol, Townsville, NC USA


[JCR상위 7.8] Clinical outcomes and predictive factors differ in acute severe ulcerative colitis for East Asian and Western patients
[JCR상위 7.8] Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study
SCIE 7.8 GASTROENTEROLOGY & HEPATOLOGY
Mak, J.
(Mak, J)
Chinese Univ Hong Kong, Internal Med, Hong Kong, Peoples R China
Chinese Univ Hong Kong, Gastroenterol, Hong Kong, Peoples R China


[JCR상위 7.8] Clinical outcomes and predictive factors differ in acute severe ulcerative colitis for East Asian and Western patients
[JCR상위 7.8] Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study
SCIE 7.8 GASTROENTEROLOGY & HEPATOLOGY
Mitrova, K.
(Mitrova, K)
Charles Univ Prague, Prague, Czech Republic
Motol Univ Hosp, Fac Med 2, Dept Paediat, Prague, Czech Republic
Charles Univ Prague, Fac Med 2, Prague, Czech Republic
Motol Univ Hosp, Dept Paediat, Prague, Czech Republic
JJF-8580-2023
Mitrova, Katarina

[JCR상위 7.8] Upadacitinib for induction of remission in pediatric Ulcerative Colitis: An international multicenter study
[JCR상위 7.8] Upadacitinib for induction of remission in pediatric Crohn's disease: An international multicenter study
SCIE 7.8 GASTROENTEROLOGY & HEPATOLOGY
Moon, J. M.
(Moon, JM)
Chung Ang Univ, Gwangmyeong Hosp, Dept Internal Med, Gwangmyeong, South Korea

[JCR상위 7.8] Long-term Efficacy and Persistence of Subcutaneous Infliximab after Switching from Intravenous Infliximab in patients with Crohn's disease: A Real-World Multicenter Prospective Cohort Study in Korea SCIE 7.8 GASTROENTEROLOGY & HEPATOLOGY
Moore, G.
(Moore, G)
Monash Hlth, Melbourne, Australia
Monash Univ, Internal Med, Melbourne, Australia
Monash Univ, Gastroenterol, Melbourne, Australia


[JCR상위 7.8] Clinical outcomes and predictive factors differ in acute severe ulcerative colitis for East Asian and Western patients
[JCR상위 7.8] Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study
SCIE 7.8 GASTROENTEROLOGY & HEPATOLOGY
Ngoi, B.
(Ngoi, B)
Royal Adelaide Hosp, Internal Med, Adelaide, Australia
Royal Adelaide Hosp, Gastroenterol, Adelaide, Australia


[JCR상위 7.8] Clinical outcomes and predictive factors differ in acute severe ulcerative colitis for East Asian and Western patients
[JCR상위 7.8] Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study
SCIE 7.8 GASTROENTEROLOGY & HEPATOLOGY
페이지 이동: